Ecto- and cytosolic 5′-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle

References

Anderson, J.L. (2004). A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction. J. Card. Fail.10, 316–320.Search in Google Scholar

Anderson, J.L., Habashi, J., Carlquist, J.F., Muhlestein, J.B., Horne, B.D., Bair, T.L., Pearson, R.R., and Hart, N. (2000). A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J. Am. Coll. Cardiol.36, 1248–1252.10.1016/S0735-1097(00)00850-0Search in Google Scholar

Arabadjis, P.G., Tullson P.C., and Terjung, R.L. (1993). Purine nucleoside formation in rat skeletal muscle fiber types. Am. J. Physiol.264, C1246–1251.10.1152/ajpcell.1993.264.5.C1246Search in Google Scholar

Bockman, E.L. and McKenzie, J.E. (1993). Tissue adenosine content in active soleus and gracilis muscles of cats. Am. J. Physiol.244, H552–559.Search in Google Scholar

Camici, M., Fini, C., and Ipata, P.L. (1985). Isolation and kinetic properties of 5′-nucleotidase from guinea-pig skeletal muscle. Biochim. Biophys. Acta840, 6–12.10.1016/0304-4165(85)90155-2Search in Google Scholar

Cheng, B., Essackjee, H.C., and Ballard, H.J. (2000). Evidence for control of adenosine metabolism in rat oxidative skeletal muscle by changes in pH. J. Physiol.522, 467–477.10.1111/j.1469-7793.2000.t01-1-00467.xSearch in Google Scholar

Crowther, G.J., Carey, M.F., Kemper, W.F., and Conley, K.E. (2002). Control of glycolysis in contracting skeletal muscle. I. Turning it on. Am. J. Physiol. Endocrinol. Metab.282, E67–E73.Search in Google Scholar

Fishbein, W.N., Griffin, J.L., and Armbrustmacher, V.W. (1980). Stain for skeletal muscle adenylate deaminase. An effective tetrazolium stain for frozen biopsy specimens. Arch. Pathol. Lab. Med.104, 462–466.Search in Google Scholar

Gastmann, A, Sigusch, H.H., Henke, A., Reinhardt, D., Surber, R., Gastmann, O., and Figulla, H.R. (2004). Role of adeno-sine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure: influence on tumor necrosis factor-α level and outcome. Am. J. Cardiol.93, 1260–1264.10.1016/j.amjcard.2004.02.011Search in Google Scholar

Gross, M. (1997). Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J. Inherit. Metab. Dis.20, 186–192.10.1023/A:1005352605421Search in Google Scholar

Gross, M., Rotzer, E., Kolle, P., Mortier, W., Reichmann, H., Goebel, H.H., Lochmüller, H., Pongratz, D., Mahnke-Zizelman, D.K., and Sabina, R.L. (2002). A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. Neuromuscul. Disord.12, 558–565.10.1016/S0960-8966(02)00008-1Search in Google Scholar

Hellsten, Y. (1999). The effect of muscle contraction on the regulation of adenosine formation in rat skeletal muscle cells. J. Physiol.518, 761–768.10.1111/j.1469-7793.1999.0761p.xSearch in Google Scholar PubMed PubMed Central

Hellsten, Y., Maclean, D., Rådegran, G., Saltin, B., and Bangsbo, J. (1998). Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation98, 6–8.10.1161/01.CIR.98.1.6Search in Google Scholar

Hellsten, Y., Richter, E.A., Kiens, B., and Bangsbo, J. (1999). AMP deamination and purine exchange in human skeletal muscle during and after intense exercise. J. Physiol.520, 909–920.10.1111/j.1469-7793.1999.00909.xSearch in Google Scholar PubMed PubMed Central

Hunsucker, S.A., Spychala, J., and Mitchell, B.S. (2001). Human cytosolic 5′-nucleotidase I: characterization and role in nucleotide analog resistance. J. Biol. Chem.276, 10498–10504.10.1074/jbc.M011218200Search in Google Scholar

Itoh, R. and Yamada, K. (1991). Determination of cytoplasmic 5′-nucleotidase which preferentially hydrolyses 6-hydroxypurine nucleotides in pig, rat and human tissues by immunotitration. Int. J. Biochem.23, 461–465.Search in Google Scholar

Itoh, R., Echizen, H., Higuchi, M., Oka, J., and Yamada, K. (1992). A comparative study on tissue distribution and metabolic adaptation of IMP-GMP 5′-nucleotidase. Comp. Biochem. Physiol. B 103, 153–159.10.1016/0305-0491(92)90427-SSearch in Google Scholar

Kalsi, K.K., Yuen, A.H., Rybakowska, I.M., Johnson, P.H., Slominska, E., Birks, K. Kaletha, K., Yacoub, M.H., and Smolenski, R.T. (2003). Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation – a potential mechanism for protection in heart failure. Cardiovasc. Res.59, 678–684.10.1016/S0008-6363(03)00497-8Search in Google Scholar

Loh, E., Rebbeck, T.R., Mahoney, P.D., DeNofrio, D., Swain, J.L., and Holmes, E.W. (1999). Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation99, 1422–1425.10.1161/01.CIR.99.11.1422Search in Google Scholar

Lynge, J., Juel, C., and Hellsten, Y. (2001). Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters. J. Physiol.537, 597–605.10.1111/j.1469-7793.2001.00597.xSearch in Google Scholar PubMed PubMed Central

Morisaki, T., Gross, M., Morisaki, H., Pongratz, D., Zöllner, N., and Holmes, E.W. (1992). Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc. Natl. Acad. Sci. USA89, 6457–6461.10.1073/pnas.89.14.6457Search in Google Scholar PubMed PubMed Central

Newby, A.C., Luzio, J.P., and Hales, C.N. (1975). The properties and extracellular location of 5′ nucleotidase of the rat fat-cell plasma membrane. Biochem. J.146, 625–633.10.1042/bj1460625Search in Google Scholar PubMed PubMed Central

Norman, B., Mahnke-Zizelman, D.K., Vallis, A., and Sabina, R.L. (1998). Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J. Appl. Physiol.85, 1273–1278.10.1152/jappl.1998.85.4.1273Search in Google Scholar PubMed

Norman, B., Sabina, R.L., and Jansson, E. (2001). Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J. Appl. Physiol.91, 258–264.10.1152/jappl.2001.91.1.258Search in Google Scholar PubMed

Rådegran, G. and Hellsten, Y. (2000). Adenosine and nitric oxide in exercise-induced human skeletal muscle vasodilatation. Acta Physiol. Scand.168, 575–591.10.1046/j.1365-201x.2000.00705.xSearch in Google Scholar PubMed

Rubio, J.C., Martin, M.A., Del Hoyo, P., Bautista, J., Campos, Y., Segura, D., Navarro, C., Ricoy, J.R., Cabello, A., and Arenas, J. (2000). Molecular analysis of Spanish patients with AMP deaminase deficiency. Muscle Nerve23, 1175–11178.10.1002/1097-4598(200008)23:8<1175::AID-MUS3>3.0.CO;2-MSearch in Google Scholar

Rohnd, J.M., Matthews, Y., and Jones, D.A. (1980). A quick simple and reliable method for ATPase in human muscle preparations. Histochem. J.12, 707–709.10.1007/BF01012026Search in Google Scholar

Rundell, K.W., Tullson, P.C., and Terjung, R.L. (1992). Altered kinetics of AMP deaminase by myosin binding. Am. J. Physiol.263, C294–299.10.1152/ajpcell.1992.263.2.C294Search in Google Scholar

Sabina, R.L., Swain, J.L., Olanow, C.W., Bradley, W.G., Fishbein, W.N., DiMauro, S., and Holmes, H.W. (1984). Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J. Clin. Invest.73, 720–730.Search in Google Scholar

Sabina, R.L., Morisaki, T., Clarke, P., Eddy, R., Shows, T.B., Morton, C.C., and Holmes, W. (1990). Characterization of the human and rat myoadenylate deaminase genes. J. Biol. Chem.265, 9423–19433.10.1016/S0021-9258(19)38866-0Search in Google Scholar

Sabina, R.L., Fishbein, W.N., Pezeshkpour, G., Clarke, P.R., and Holmes, E.W. (1992). Molecular analysis of the myoadenylate deaminase deficiencies. Neurology42, 170–179.10.1212/WNL.42.1.170Search in Google Scholar

Tarnopolsky, M.A., Parise, G., Gibala, M.J., Graham, T.E., and Rush, J.W.E. (2001). Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J. Physiol.533, 881–889.10.1111/j.1469-7793.2001.t01-1-00881.xSearch in Google Scholar

Tullson, P.C. and Terjung, R.L. (1991). Adenosine nucleotide metabolism in contracting skeletal muscle. Exer. Sport Sci. Rev.14, 507–536.Search in Google Scholar

Tullson, P.C. and Terjung, R.L. (1999). IMP degradative capacity in rat skeletal muscle fiber types. Mol. Cell. Biochem.199, 111–117.10.1023/A:1006924318114Search in Google Scholar

Tullson, P.C., Whitlock, D.M., and Terjung, R.L. (1990). Adenine nucleotide degradation in slow-twitch red muscle. Am. J. Physiol.258, C258–265.10.1152/ajpcell.1990.258.2.C258Search in Google Scholar

Verzijl, H.T., van Engelen, B.G., Luyten, J.A., Steenbergen, G.C., van den Heuvel, L.P., ter Laak, H.J., Padberg, G.W., and Wevers, R.A. (1998). Genetic characterization of myoadenylate deaminase deficiency. Ann. Neurol.44, 140–143.10.1002/ana.410440124Search in Google Scholar

Yazaki, Y., Muhlestein, J.B., Carlquist, J.F., Bair, T.L., Horne, B.D., Renlund, D.G., and Anderson, J.L. (2004). A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction. J. Card. Fail.10, 316–1320.10.1016/j.cardfail.2003.10.008Search in Google Scholar

Zimmermann, H. (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg's Arch. Pharmacol.362, 299–309.10.1007/s002100000309Search in Google Scholar PubMed

Zöllner, N., Reiter, S., and Gross, M. (1986). Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin. Wochenschr.64, 1281–1290.10.1007/BF01785710Search in Google Scholar PubMed